Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2018

Open Access 01-12-2018 | Research article

The impact of sarcopenic obesity on knee and hip osteoarthritis: a scoping review

Authors: Kristine Godziuk, Carla M. Prado, Linda J. Woodhouse, Mary Forhan

Published in: BMC Musculoskeletal Disorders | Issue 1/2018

Login to get access

Abstract

Background

The progressive, debilitating nature of knee and hip osteoarthritis can result in severe, persistent pain and disability, potentially leading to a need for total joint arthroplasty (TJA) in end-stage osteoarthritis. TJA in adults with obesity is associated with increased surgical risk and prolonged recovery, yet classifying obesity only using body mass index (BMI) precludes distinction of obesity phenotypes and their impact on surgical risk and recovery. The sarcopenic obesity phenotype, characterized by high adiposity and low skeletal muscle mass, is associated with higher infection rates, poorer function, and slower recovery after surgery in other clinical populations, but not thoroughly investigated in osteoarthritis. The rising prevalence and impact of this phenotype demands further attention in osteoarthritis treatment models of care, particularly as osteoarthritis-related pain, disability, and current treatment practices may inadvertently be influencing its development.

Methods

A scoping review was used to examine the extent of evidence of sarcopenic obesity in adults with hip or knee osteoarthritis. Medline, CINAHL, Web of Science and EMBASE were systematically searched from inception to December 2017 with keywords and subject headings related to obesity, sarcopenia and osteoarthritis.

Results

Eleven studies met inclusion criteria, with indications that muscle weakness, low skeletal muscle mass or sarcopenia are present alongside obesity in this population, potentially impacting therapeutic outcomes, and TJA surgical risk and recovery.

Conclusions

Consideration of sarcopenic obesity should be included in osteoarthritis patient assessments.
Literature
1.
Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States, part II for the National Arthritis Data Workgroup. Arthritis Rheum. 2008;58(1):26–35.CrossRefPubMedPubMedCentral
2.
Bombardier C, Hawker G, Mosher D. The impact of arthritis in Canada : today and over the next 30 years. Arthritis Alliance of Canada. 2011;
3.
Bastick A, Runhaar J, Belo J, Bierma-Zeinstra S. Prognostic factors for progression of clinical osteoarthritis of the knee: a systematic review of observational studies. Arthritis Res Ther. 2015;17(152):1–13.
4.
Tian W, DeJong G, Brown M, Hsieh CH, Zamfirov ZP, Horn SD. Looking upstream: factors shaping the demand for postacute joint replacement rehabilitation. Arch Phys Med Rehabil. 2009;90(8):1260–8.CrossRefPubMed
5.
6.
Canadian Joint Replacement Registry. 2002 Report Total Hip and Total Knee Replacements in Canada.; 2002.
7.
Canadian Institute for Health Information (CIHI). Hip and Knee Replacements in Canada: Canadian Joint Replacement Registry 2015–2016 Quick Stats.; 2017.
8.
OECD/EU. Health at a Glance: Europe 2016 – State of Health in the EU Cycle. Paris; 2016.
9.
Dowsey MM, Gunn J, Choong PFM. Selecting those to refer for joint replacement: who will likely benefit and who will not? Best Pract Res Clin Rheumatol. 2014;28(1):157–71.CrossRefPubMed
10.
Kerkhoffs GMMJ, Servien E, Dunn W, Dahm D, Bramer JAM, Haverkamp D. The influence of obesity on the complication rate and outcome of total knee arthroplasty. J Bone Jt Surg. 2012;94(20):1839–44.CrossRef
11.
Si H, Zeng Y, Shen B, et al. The influence of body mass index on the outcomes of primary total knee arthroplasty. Knee surgery, Sport Traumatol Arthrosc. 2015;23(6):1824–32.CrossRef
12.
Samson AJ, Mercer GE, Campbell DG. Total knee replacement in the morbidly obese: a literature review. ANZ J Surg. 2010;80(9):595–9.CrossRefPubMed
13.
American Academy of Orthopaedic Surgeons. Management of Osteoarthritis of the Hip: Evidence-Based Clinical Practice Guideline.; 2017.
14.
Springer B, Parvizi J, Austin M, et al. Obesity and total joint arthroplasty. A literature based review. J Arthroplast. 2013;28(5):714–21.CrossRef
15.
Vaishya R, Vijay V, Wamae D, Agarwal AK. Is total knee replacement justified in the morbidly obese? A systematic review. Cureus. 2016;8(9):e804.PubMed
16.
Springer BD, Carter JT, McLawhorn AS, et al. Obesity and the role of bariatric surgery in the surgical management of osteoarthritis of the hip and knee: a review of the literature. Surg Obes Relat Dis. 2016:1–8.
17.
18.
Vasarhelyi EM, MacDonald SJ. The influence of obesity on total joint arthroplasty. J Bone Joint Surg Br. 2012;94(11 Suppl A):100–102.
19.
Roth KC, Bessems G. Sorry, but you will have to lose weight before receiving your knee replacement. Erasmus J Med. 2013;3(2):54–7.
20.
Lui M, Jones CA, Westby MD. Effect of non-surgical, non-pharmacological weight loss interventions in patients who are obese prior to hip and knee arthroplasty surgery: a rapid review. Syst Rev. 2015;4(1):121.CrossRefPubMedPubMedCentral
21.
Demling RH. Nutrition, anabolism, and the wound healing process: an overview. Eplasty. 1954;9:65–94.
22.
Prado CM, Gonzalez MC, Heymsfield SB. Body composition phenotypes and obesity paradox. Curr Opin Clin Nutr Metab Care. 2015;18(6):535–51.CrossRefPubMed
23.
Kuk JL, Lee S, Heymsfield SB, Ross R. Waist circumference and abdominal adipose tissue distribution: influence of age and sex. Am J Clin Nutr. 2005;81(6):1330–4.CrossRefPubMed
24.
Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010;31(6):737–46.CrossRefPubMed
25.
Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701.CrossRefPubMed
26.
Johnson Stoklossa C, Sharma A, Forhan M, Siervo M, Padwal R, Prado C. Prevalence of sarcopenic obesity in adults with class II/III obesity using different diagnostic criteria. J Nutr Metab. 2017;
27.
Gonzalez MC, Correia MITD, Heymsfield SB. A requiem for BMI in the clinical setting. Curr Opin Clin Nutr Metab Care. 2017;20(5):1.CrossRef
28.
Nishigori T, Tsunoda S, Okabe H, et al. Impact of sarcopenic obesity on surgical site infection after laparoscopic total gastrectomy. Ann Surg Oncol. 2016:524–31.
29.
Visser M, van Venrooij LMW, Vulperhorst L, et al. Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery. Nutr Metab Cardiovasc Dis. 2013;23(6):511–8.CrossRefPubMed
30.
Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35.CrossRefPubMed
31.
32.
Prado CM, Siervo M, Mire E, et al. A population-based approach to define body-composition. Am J Clin Nutr. 2014:1369–78.
33.
Cherin P, Voronska E, Fraoucene N, De Jaeger C. Prevalence of sarcopenia among healthy ambulatory subjects: the sarcopenia begins from 45 years. Aging Clin Exp Res. 2014;26(2):137–46.CrossRefPubMed
34.
Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr. 2002;50:889–96.CrossRef
35.
Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab. 2014;11(3):177–80.PubMedPubMedCentral
36.
Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol: Biol Sci. 2002;57:B359–B365.
37.
38.
Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004;12(12):1995–2004.CrossRefPubMed
39.
Tian S, Xu Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr Gerontol Int. 2016;16:155–66.CrossRefPubMed
40.
Prado CM, Wells JCK, Smith SR, Stephan BCM, Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr. 2012;31(5):583–601.CrossRefPubMed
41.
42.
Organization for Economic Cooperation and Development. Obesity Update, 2017.
43.
Roubenoff R. Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci. 2000;904:553–7.CrossRefPubMed
44.
Juby AG. A healthy body habitus is more than just a normal BMI: implications of sarcopenia and sarcopenic obesity. Maturitas. 2014;78(4):243–4.CrossRefPubMed
45.
Thijssen E, van Caam A, van der Kraan PM. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology. 2015;54(4):588–600.CrossRefPubMed
46.
Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388–95.CrossRefPubMed
47.
Lee D, Drenowatz C, Blair SN. Physical activity and sarcopenic obesity: definition, assessment, prevalence and mechanism. Futur Sci. 2016;
48.
Griffin TM, Huffman KM. Insulin resistance: releasing the brakes on synovial inflammation and osteoarthritis? Arthritis Rheumatol. 2016;68(6):1–30.CrossRef
49.
50.
De Ceuninck F, Fradin A, Pastoureau P. Bearing arms against osteoarthritis and sarcopenia: when cartilage and skeletal muscle find common interest in talking together. Drug Discov Today. 2014;19(3):305–11.CrossRefPubMed
51.
Papalia R, Zampogna B, Torre G, et al. Sarcopenia and its relationship with osteoarthritis: risk factor or direct consequence? Musculoskelet Surg. 2014;98(1):9–14.CrossRefPubMed
52.
Karlsson MK, Magnusson H, Coster M, Karlsson C, Rosengren BE. Patients with knee osteoarthritis have a phenotype with higher bone mass, higher fat mass, and lower lean body mass. Clin Orthop Relat Res. 2015;473(1):258–64.CrossRefPubMed
53.
Karlsson MK, Magnusson H, Coster MC, Vonschewelov T, Karlsson C, Rosengren BE. Patients with hip osteoarthritis have a phenotype with high bone mass and low lean body mass. Clin Orthop Relat Res. 2014;472(4):1224–9.CrossRefPubMed
54.
Karlsson MK, Karlsson C, Magnusson H, et al. Individuals with primary osteoarthritis have different phenotypes depending on the affected joint - a case control study from southern Sweden including 514 participants. Open Orthop J. 2014;8:450–6.CrossRefPubMedPubMedCentral
55.
Purcell S, Thornberry R, Elliott SA, et al. Body composition, strength, and dietary intake of patients with hip or knee osteoarthritis. Can J Diet Pract Res. 2016;77:1–5.CrossRef
56.
Visser AW, de Mutsert R, Loef M, et al. The role of fat mass and skeletal muscle mass in knee osteoarthritis is different for men and women: the NEO study. Osteoarthr Cartil. 2014;22(2):197–202.CrossRefPubMed
57.
58.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.CrossRef
59.
Batsis JA, Zbehlik AJ, Pidgeon D, Bartels SJ. Dynapenic obesity and the effect on long-term physical function and quality of life: data from the osteoarthritis initiative. BMC Geriatr. 2015;15(1):118.CrossRefPubMedPubMedCentral
60.
Ji HM, Han J, Jin DS, Suh H, Chung YS, Won YY. Sarcopenia and sarcopenic obesity in patients undergoing orthopedic surgery. Clin Orthop Surg. 2016;8(2):194–202.CrossRefPubMedPubMedCentral
61.
Jin WS, Choi EJ, Lee SY, Bae EJ, Lee T, Park J. Relationships among obesity, sarcopenia, and osteoarthritis in the elderly. J Obes Metab Syndr. 2017:36–44.
62.
Knoop J, Van Der Leeden M, Thorstensson CA, et al. Identification of phenotypes with different clinical outcomes in knee osteoarthritis: data from the osteoarthritis initiative. Arthritis Care Res. 2011;63(11):1535–42.CrossRef
63.
Lee SY, Ro HJ, Chung SG, Kang SH, Seo KM, Kim DK. Low skeletal muscle mass in the lower limbs is independently associated to knee osteoarthritis. PLoS One. 2016;11(11):1–11.
64.
Lee S, Kim TN, Kim SH. Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study. Arthritis Rheum. 2012;64(12):3947–54.CrossRefPubMed
65.
Manoy P, Anomasiri W, Yuktanandana P, et al. Elevated serum leptin levels are associated with low vitamin D, sarcopenic obesity, poor muscle strength, and physical performance in knee osteoarthritis. Biomarkers. 2017:1–22.
66.
Oosting E, Hoogeboom TJ, Dronkers JJ, Visser M, Akkermans RP, NLU VM. The influence of muscle weakness on the association between obesity and inpatient recovery from total hip arthroplasty. J Arthroplasty. 2016;
67.
Segal NA, Toda Y. Absolute reduction in lower limb lean body mass in Japanese women with knee osteoarthritis. J Clin Rheumatol. 2005;11(5):245–9.CrossRefPubMed
68.
Suh DH, Han KD, Hong JY, et al. Body composition is more closely related to the development of knee osteoarthritis in women than men: a cross-sectional study using the fifth Korea National Health and nutrition examination survey (KNHANES V-1, 2). Osteoarthr Cartil. 2016;24(4):605–11.CrossRefPubMed
69.
Clémence J, Bernard M, Lorraine B, Francis G, Anne-Christine R. Body composition and clinical symptoms in patients with hip or knee osteoarthritis: results from the KHOALA cohort. Semin Arthritis Rheum. 2017;
70.
Newman AB, Kupelian V, Visser M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51(11):1602–9.CrossRefPubMed
71.
Bosy-Westphal A, Müller MJ. Identification of skeletal muscle mass depletion across age and BMI groups in health and disease - there is need for a unified definition. Int J Obes. 2015;39(3):379–86.CrossRef
72.
Donini LM, Poggiogalle E, Migliaccio S, Aversa A, Pinto A. Body composition in sarcopenic obesity: systematic review of the literature. Med J Nutrition Metab. 2013;6(3):191–8.CrossRef
73.
Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez-Jimenez F, Bartels SJ. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and nutrition examination survey 1999-2004. J Am Geriatr Soc. 2013;61(6):974–80.CrossRefPubMed
74.
Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “ cachexia-anorexia in chronic wasting diseases” and “ nutrition in geriatrics.”. Clin Nutr. 2010;29(2):154–9.CrossRefPubMed
75.
Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–56.CrossRefPubMed
76.
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates. Journals Gerontol - Ser A Biol Sci Med Sci. 2014;69 A(5):547–558.
77.
Ilich JZ, Kelly OJ, Inglis JE. Osteosarcopenic obesity syndrome: what is it and how can it be identified and diagnosed? Curr Gerontol Geriatr Res. 2016;
78.
Tsonga T, Michalopoulou M, Malliou P, et al. Analyzing the history of falls in patients with severe knee osteoarthritis. Clin Orthop Surg. 2015;7(4):449–56.CrossRefPubMedPubMedCentral
79.
80.
Shyam Kumar AJ, Beresford-Cleary N, Kumar P, et al. Preoperative grip strength measurement and duration of hospital stay in patients undergoing total hip and knee arthroplasty. Eur J Orthop Surg Traumatol. 2013;23:553–6.CrossRefPubMed
81.
Mau-Moeller A, Behrens M, Felser S, et al. Modulation and predictors of periprosthetic bone mineral density following total knee arthroplasty. Biomed Res Int. 2015.
82.
Prado CM, Heymsfield SB. Lean tissue imaging: a new era for nutritional assessment and intervention. J Parenter Enter Nutr. 2014;38(8):940–53.CrossRef
Metadata
Title
The impact of sarcopenic obesity on knee and hip osteoarthritis: a scoping review
Authors
Kristine Godziuk
Carla M. Prado
Linda J. Woodhouse
Mary Forhan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2018
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-018-2175-7

Other articles of this Issue 1/2018

BMC Musculoskeletal Disorders 1/2018 Go to the issue

Research article

Measure of activity performance of the hand (MAP-Hand) questionnaire: linguistic validation, cultural adaptation and psychometric testing in people with rheumatoid arthritis in the UK

Research article

Distal biceps tendon rupture: advantages and drawbacks of the anatomical reinsertion with a modified double incision approach

Research article

Diagnostic strategy for elderly patients with isolated greater trochanter fractures on plain radiographs

Research article

Promoting the use of self-management in novice chiropractors treating individuals with spine pain: the design of a theory-based knowledge translation intervention

Research article

Kinesio taping reduces elbow pain during resisted wrist extension in patients with chronic lateral epicondylitis: a randomized, double-blinded, cross-over study

Research article

Effects of multilevel posterior ligament dissection after spinal instrumentation on adjacent segment biomechanics as a potential risk factor for proximal junctional kyphosis: a biomechanical study